Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
ImmuneOnco Biopharma
company
About
ImmuneOnco is a tumor immunotherapy product developer engaged in the development and research of tumor immunotherapy products.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $15.80M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jun 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$140.80M
ImmuneOnco Biopharma has raised a total of
$140.80M
in funding over 2 rounds. Their latest funding was raised on
Dec 31, 2021 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 31, 2021 | Series Unknown | $100M | 2 | — | — | Detail |
| Oct 12, 2020 | Series B | $25M | 2 |
Lilly Asia Ventures
|
— | Detail |
| Apr 11, 2018 | Series A | $15.80M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
ImmuneOnco Biopharma is funded by 3 investors.
Milestone
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Milestone
|
— | Series Unknown |
|
Lilly Asia Ventures
|
— | Series Unknown |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
